Loading...
Images of Lorenza Rimassa
(0 from 0 )1
0
0
News
PosterSessionOnline
www.postersessiononline.eu
Authors: Lorenza Rimassa , Silvia Bozzarelli, Stefano Cordio, Laura Toppo, Sara Lonardi, Alberto Zaniboni, Roberto Bordonaro, Wanda ...
Network Profiles
LinkedIn: Lorenza Rimassa - Deputy Director - Medical Oncology …
Découvrez le profil de Lorenza Rimassa sur LinkedIn, la plus grande communauté professionnelle au monde. Lorenza indique 7 postes sur son profil. Consultez le profil complet sur LinkedIn et découvrez les relations de Lorenza, ainsi que des emplois dans des entreprises similaires.
LinkedIn: Lorenza Rimassa - Deputy Director - Medical Oncology …
Se Lorenza Rimassas profil på LinkedIn, världens största yrkesnätverk. Lorenza har angett 7 jobb i sin profil. Se hela profilen på LinkedIn, upptäck Lorenzas kontakter och hitta jobb på liknande företag.
LinkedIn: Lorenza Rimassa - Deputy Director - Medical Oncology …
Ve el perfil de Lorenza Rimassa en LinkedIn, la mayor red profesional del mundo. Lorenza tiene 7 empleos en su perfil. Ve el perfil completo en LinkedIn y descubre los contactos y empleos de Lorenza en empresas similares.
Interests
ArQule Announces Interim Phase 2 Study Results for Tivantinib in...
www.businesswire.com
... number O-008) by Dr. Lorenza Rimassa, MD, Deputy Director, Medical Oncology Unit at Humanitas Cancer Center, in Rozzano (Milan, Italy).
Books & Literature
Tivantinib for second-line treatment of advanced hepatocellular...
biblio.ugent.be
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study Armando Santoro, Lorenza Rimassa, Ivan ...
Tumor and circulating biomarkers in patients with second-line...
biblio.ugent.be
Lorenza Rimassa, Giovanni Abbadessa, Nicola Personeni, Camillo Porta, Ivan Borbath, Bruno Daniele, Stefania Salvagni, Jean-Luc Van ...
Related Documents
ASCO Proceedings (pp - National Cancer Institute
ccrod.cancer.gov
Armando Santoro, Camillo Porta, Lorenza Rimassa, Ivan Borbath, Bruno Daniele , Richard S. Finn,. Jean-Luc Raoul, Lawrence H. Schwartz, Aiwu Ruth He, Jorg ...
EBSCOhost | | Oral ulcer as an exclusive sign of gastric...
web.a.ebscohost.com
Lorenza Rimassa - ; Duccio Petrella - ;. Armando Santoro ...
Tumor and plasma biomarker analysis from the randomized controlled ...
hwmaint.meeting.ascopubs.org
Lorenza Rimassa, Giovanni Abbadessa, Nicola Personeni, Camillo Porta, Ivan Borbath, Bruno Daniele, Jean-Luc Van Laethem, Hans Van Vlieberghe, Jorg ...
Unexpected low efficacy of stealth liposomal doxorubicin (Caelyx) and...
www.proquest.com
Lorenza Rimassa, Carlo Carnaghi, Isabella Garassino, Piermario Salvini, Valeria Ginanni,. Giuseppe Gullo, Emanuela Morenghi, and Armando Santoro.
Scientific Publications
Oral ulcer as an exclusive sign of gastric cancer: report of a rare...
bmccancer.biomedcentral.com
Oral ulcer as an exclusive sign of gastric cancer: report of a rare case. Piergiuseppe Colombo 1 *, Luca Tondulli 2, Giovanna Masci 2, Andrea Muzza 3, Lorenza Rimassa ...
World Journal of Surgical Oncology reviewer acknowledgement |...
wjso.biomedcentral.com
Lorenza Rimassa. Italy. Yasushi Rino. Japan. Jan Lukas Robertus. Netherlands. Stuart Robinson. United Kingdom. Juan Pablo Rodrigo. Spain.
Publications
Adrenal metastases from adenocarcinoma of the esophagogastric...
link.springer.com
Lorenza Rimassa (2) Mario Bignardi (3) Riccardo Rosati (1) (4) Author Affiliations. 1. Department of General and Minimally Invasive Surgery, Istituto Clinico ...
Oral ulcer as an exclusive sign of gastric cancer: report of a rare...
link.springer.com
Background The oral cavity is a rare but occasional target for metastases, which may masquerade as various benign and inflammatory lesions, and sometimes also...
The efficacy of hybrid chemotherapy with intravenous oxaliplatin and...
link.springer.com
Intra-arterial chemotherapy in patients with liver metastases from colorectal cancer has some limitations such as hepatic toxicity and extra-hepatic...
Unexpected Low Efficacy of Stealth Liposomal Doxorubicin (Caelyx) and...
link.springer.com
Authors. Lorenza Rimassa (1); Carlo Carnaghi (1); Isabella Garassino (1); Piermario Salvini (1); Valeria Ginanni (1); Giuseppe Gullo (1); Emanuela Morenghi (1) ...
Reports & Statements
CrossRef Cited By Search Results : nature.com
www.nature.com
Nature - the world's best science and medicine on your desktop
La cura dell’ epatocarcinoma | 4lofting
4lofting.wordpress.com
“Fino alla scoperta di questo nuovo principio attivo – spiega la dott.ssa Lorenza Rimassa, vice-responsabile di Oncologia Medica di Humanitas ...
Tumore del fegato, nuove prospettive - Aimac - Forum sul tumore
forumtumore.aimac.it
<r><B><s>[b]</s><U><s>[u]</s>Riporto di seguito l'articolo pubblicato sul sito della Clinica Humanitas di Rozzano, in...
Miscellaneous
Lorenza Rimassa | LinkedIn
www.linkedin.com
View Lorenza Rimassa's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Lorenza Rimassa discover inside ...
Lorenza Rimassa - Deputy Director - Medical Oncology …
www.linkedin.com
View Lorenza Rimassa’s profile on LinkedIn, the world's largest professional community. Lorenza has 7 jobs listed on their profile. See the complete profile on LinkedIn and discover Lorenza’s connections and jobs at similar companies.
Abstracts Jordan Berlin, MD - ppt video online download
slideplayer.com
Disclosures With regards to these presentations: I have done an advisory board and have had multiple trials with Amgen, Vanderbilt has trials open from Daiichi...
Dr. Lorenza Rimassa on Tivantinib for EGFR Inhibitor-Resistant mCRC
www.onclive.com
Lorenza Rimassa, MD, Deputy Director - Medical Oncology Unit - Humanitas Cancer Center, Humanitas Research Hospital, discusses a study looking at tivantinib (ARQ 197), a highly selective MET inhibitor, for the treatment of …
Lorenza Rimassa – Network — Italian Ministry of Health
moh-it.pure.elsevier.com
Fanotto, Valentina. Azienda Ospedaliero Universitaria Sm Della Misericordia; University and General Hospital; University and General Hospital; University of Udine
Lorenza Rimassa — Italian Ministry of Health
moh-it.pure.elsevier.com
Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines …
Lorenza Rimassa
www.infona.pl
Background Ramucirumab—alone or combined with paclitaxel—represents one of the main options for patients failing first-line treatment for advanced gastric cancer.
Feasibility and Results of Radical Surgery and Adjuvant Therapy in...
www.serena.unina.it
Feasibility and Results of Radical Surgery and Adjuvant Therapy in Patients Older than 70 Years with Pancreatic Adenocarcinoma
Tumor and circulating biomarkers in patients with second-line...
www.oncotarget.com
https://doi.org oncotarget Lorenza Rimassa, Giovanni Abbadessa, Nicola Personeni, Camillo Porta, Ivan Borbath, Bruno Daniele, Stefania Salvagni,...
Journals on the Web
journals.prous.com
by Giovanni Abbadessa, Paraskevi Vogiatzi, Lorenza Rimassa and Pier Paolo Claudio Drug News Perspect 2007, 20(5): Summary | Full Text: HTML, PDF.
Study of Tivantinib (ARQ 197) Plus Cetuximab in EGFR...
clinicaltrials.gov
Lorenza Rimassa, MD: Istituto Clinico Humanitas: More Information. No publications provided . Responsible Party: Armando Santoro, MD, Medical Doctor - Oncologist ...
Diagnostic accuracy of 11C-choline PET/CT in comparison with CT...
www.infona.pl
Egesta Lopci, Guido Torzilli, Dario Poretti, Lauro J. Souza Neto, Matteo Donadon, Lorenza Rimassa, Ezio Lanza, Juliano Guerra Sabongi, Roberto Ceriani, ...
Humanitas, nuovo centro per malattie pancreas e duodeno - Cronaca -...
www.ilgiorno.it
In occasione del World Pancreatic Cancer Day, l'Istituto presenta il Centro che unisce le forti competenze diagnostiche a quelle chirurgiche ed oncologiche per...
Fegato, nuovo farmaco intelligente. "Un cecchino che colpisce i...
www.affaritaliani.it
Un 'cecchino' in grado di colpire con precisione il bersaglio. È il nuovo farmaco intelligente testato per la cura dell'epatocarcinoma, il...
La Rivista 'Tumori' - Fondazione IRCCS Istituto Nazionale Tumori di...
vecchiosito.istitutotumori.mi.it
La Rivista 'Tumori'
Nuove terapie in oncologia - Prevenzione Tumori
www.prevenzionetumori.it
Nuove frontiere si sono aperte nel campo della medicina. Da farmaci chemioterapici più efficaci a terapie biologiche e ormonali innovative. Con conseguente...
O-029 Tivantinib in Pretreated Hepatocellular Carcinoma (HCC): Tumour...
webcasts.nextmeeting.eu
Presenter: Lorenza Rimassa. Lorenza Rimassa 1,*, Giovanni Abbadessa 2, Nicola Personeni 1 3, Camillo Porta 4, Ivan Borbath 5, Bruno Daniele 6, Stefania ...
PROGRAMMA
www.events-communication.net
I SESSION: CLINICAL EVIDENCES WITH ANTI-ANGIOGENIC DRUGS. CHAIRS: Filippo de Braud, Vittorina Zagonel Epatocarcinoma Lorenza Rimassa.
Phase II study of NGR-hTNF, a selective vascular targeting agent, in...
www.infona.pl
Armando Santoro, Lorenza Rimassa, Alberto F. Sobrero, Giovanni Citterio, Francesco Sclafani, Carlo Carnaghi, Anna ... Lorenza Rimassa.
Tivantinib Biomarker Analysis Validates Phase III Design
www.targetedonc.com
Treatment with tivantinib has proven highly effective in patients with hepatocellular carcinoma and with high MET expression, suggesting a prognostic and...
Related search requests for Lorenza Rimassa
Nicola Personeni Emanuela Morenghi Francesco Sclafani | Luca Tondulli Giuseppe Gullo Carlo Carnaghi |
People Forename "Lorenza" (1056) Name "Rimassa" (10) |
sorted by relevance / date